Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01636882
What this trial is testing

CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)

Who this might be right for
Melanoma
Viralytics 16
Testing effectiveness (Phase 2)Study completedNCT00462423
What this trial is testing

Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study

Who this might be right for
Metastatic Malignant Melanoma
Lynn E. Spitler, MD 50
Not applicableStudy completedNCT06189261
What this trial is testing

Holistic Needs Assessments in Patients With Melanoma

Who this might be right for
MelanomaUnsatisfied Needs
University of Surrey 30
Not applicableUnknownNCT05463523
What this trial is testing

A Multi-centric Clinical Trial in China for Skin Diseases Intelligent Diagnosis and Treatment System

Who this might be right for
Skin DiseasesArtificial IntelligenceAugmented Reality+1 more
Xiangya Hospital of Central South University 200
Early research (Phase 1)Ended earlyNCT02097225
What this trial is testing

Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Malignant Solid Neoplasm+7 more
National Cancer Institute (NCI) 22
Not applicableStudy completedNCT06257888
What this trial is testing

A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients

Who this might be right for
Breast Neoplasm Malignant Primary
Renato Cagnacci Neto 90
Not applicableStudy completedNCT05408260
What this trial is testing

Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer

Who this might be right for
Malignant Breast Neoplasm
Thomas Jefferson University 12
Early research (Phase 1)Study completedNCT00356460
What this trial is testing

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Who this might be right for
Carcinoma, Renal CellMelanoma
Genzyme, a Sanofi Company 29
Not applicableEnded earlyNCT00610818
What this trial is testing

Effect of Palifermin on Skin Tumors in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Skin Rash
McGill University Health Centre/Research Institute of the McGill University Health Centre 7
Early research (Phase 1)Active Not RecruitingNCT05362773
What this trial is testing

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics 130
Testing effectiveness (Phase 2)Ended earlyNCT00104884
What this trial is testing

FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Malignant MelanomaMelanoma
ECOG-ACRIN Cancer Research Group 4
Early research (Phase 1)Study completedNCT03667716
What this trial is testing

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Who this might be right for
Advanced CancerOvarian CancerBreast Cancer+7 more
Compugen Ltd 121
Not applicableStudy completedNCT03197636
What this trial is testing

Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients

Who this might be right for
Malignant Melanoma
Aarhus University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00005971
What this trial is testing

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 17
Not applicableStudy completedNCT06613230
What this trial is testing

Improved Early Diagnosis in Female Pelvic Cancer With OC Detect

Who this might be right for
Ovarian CancerEndometrial CancerBreast Cancer+3 more
Region Skane 490
Early research (Phase 1)Study completedNCT02897765
What this trial is testing

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

Who this might be right for
Urinary Bladder CancerBladder TumorsTransitional Cell Carcinoma of the Bladder+5 more
BioNTech US Inc. 34
Testing effectiveness (Phase 2)UnknownNCT02759536
What this trial is testing

In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma

Who this might be right for
MelanomaBoron Neutron Capture Therapy
The Third Xiangya Hospital of Central South University 30
Very early researchUnknownNCT03649529
What this trial is testing

Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

Who this might be right for
Malignant Melanoma
Timmune Biotech Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00831545
What this trial is testing

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Who this might be right for
Metastases of Central Nervous SystemMelanomaBreast Neoplasm+1 more
Merck Sharp & Dohme LLC 162
Testing effectiveness (Phase 2)Study completedNCT00338130
What this trial is testing

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Who this might be right for
Melanoma
AstraZeneca 239
Next Page